Latest filing published 30 Aug 2017 for Zomedica Pharmaceuticals Corp., €7,949.
Jane Shirley Eagleson appears in our data through filings on Zomedica Pharmaceuticals Corp. shares, published by SEDI. In total, 3 filings cover trades dated from 4 October 2016 to 29 August 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 30 August 2017 came the latest disclosure, an option exercise for €7,949 in Zomedica Pharmaceuticals Corp. Typically, a trade is published a median of 1 day after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations